Routes to manipulate MHC class II antigen presentation

Current Opinion in Immunology

Volumn 23, Issue 1, 2011, Pages 88-95

  van den Hoorn, Tineke ^a   Paul, Petra ^a   Jongsma, Marlieke LM ^a   Neefjes, Jacques ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN INHIBITOR; ENZYME INHIBITOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CELL MEMBRANE; DENDRITIC CELL; ENDOPLASMIC RETICULUM; ENDOSOME; EXOSOME; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INTERNALIZATION; MELANOMA; NONHUMAN; REVIEW;

ANIMALS; ANTIGEN PRESENTATION; CELL MEMBRANE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; PROTEIN TRANSPORT; VACCINATION;

EID: 79951679620     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2010.11.002     Document Type: Review

References (74)

1. Dugast M., Toussaint H., Dousset C., Benaroch P. AP2 clathrin adaptor complex, but not AP1, controls the access of the major histocompatibility complex (MHC) class II to endosomes. J Biol Chem 2005, 280:19656-19664.
2. Gupta S.N., Kloster M.M., Rodionov D.G., Bakke O. Re-routing of the invariant chain to the direct sorting pathway by introduction of an AP3-binding motif from LIMP II. Eur J Cell Biol 2006, 85:457-467.
3. McCormick P.J., Martina J.A., Bonifacino J.S. Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments. Proc Natl Acad Sci U S A 2005, 102:7910-7915.
4. Neefjes J.J., Stollorz V., Peters P.J., Geuze H.J., Ploegh H.L. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 1990, 61:171-183.
5. Peters P.J., Neefjes J.J., Oorschot V., Ploegh H.L., Geuze H.J. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 1991, 349:669-676.
6. Roche P.A., Cresswell P. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 1990, 345:615-618.
7. Kropshofer H., Vogt A.B., Moldenhauer G., Hammer J., Blum J.S., Hammerling G.J. Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J 1996, 15:6144-6154.
8. Zwart W., Griekspoor A., Kuijl C., Marsman M., van Rheenen J., Janssen H., Calafat J., van Ham M., Janssen L., van Lith M., et al. Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape. Immunity 2005, 22:221-233.
9. Burgdorf S., Kurts C. Endocytosis mechanisms and the cell biology of antigen presentation. Curr Opin Immunol 2008, 20:89-95.
10. Souwer Y., Griekspoor A., Jorritsma T., de Wit J., Janssen H., Neefjes J., van Ham S.M. B cell receptor-mediated internalization of salmonella: a novel pathway for autonomous B cell activation and antibody production. J Immunol 2009, 182:7473-7481.
11. Kamphorst A.O., Guermonprez P., Dudziak D., Nussenzweig M.C. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes. J Immunol 2010, 185:3426-3435.
12. Mao Y.S., Yamaga M., Zhu X., Wei Y., Sun H.Q., Wang J., Yun M., Wang Y., Di Paolo G., Bennett M., et al. Essential and unique roles of PIP5K-gamma and -alpha in Fcgamma receptor-mediated phagocytosis. J Cell Biol 2009, 184:281-296.
13. Platt C.D., Ma J.K., Chalouni C., Ebersold M., Bou-Reslan H., Carano R.A., Mellman I., Delamarre L. Mature dendritic cells use endocytic receptors to capture and present antigens. Proc Natl Acad Sci U S A 2010, 107:4287-4292.
14. Birkholz K., Schwenkert M., Kellner C., Gross S., Fey G., Schuler-Thurner B., Schuler G., Schaft N., Dorrie J. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation. Blood 2010, 116:2277-2285.
15. Rammensee H., Bachmann J., Emmerich N.P., Bachor O.A., Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999, 50:213-219.
16. Mizushima N., Yamamoto A., Hatano M., Kobayashi Y., Kabeya Y., Suzuki K., Tokuhisa T., Ohsumi Y., Yoshimori T. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol 2001, 152:657-668.
17. Nedjic J., Aichinger M., Mizushima N., Klein L. Macroautophagy, endogenous MHC II loading and T cell selection: the benefits of breaking the rules. Curr Opin Immunol 2009, 21:92-97.
18. Nedjic J., Aichinger M., Emmerich J., Mizushima N., Klein L. Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature 2008, 455:396-400.
19. Lee H.K., Mattei L.M., Steinberg B.E., Alberts P., Lee Y.H., Chervonsky A., Mizushima N., Grinstein S., Iwasaki A. In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity 2010, 32:227-239.
20. Gannage M., Munz C. Monitoring macroautophagy by major histocompatibility complex class II presentation of targeted antigens. Methods Enzymol 2009, 452:403-421.
21. Singh R., Cresswell P. Defective cross-presentation of viral antigens in GILT-free mice. Science 2010, 328:1394-1398.
22. Arunachalam B., Phan U.T., Geuze H.J., Cresswell P. Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci U S A 2000, 97:745-750.
23. Rausch M.P., Irvine K.R., Antony P.A., Restifo N.P., Cresswell P., Hastings K.T. GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1. J Immunol 2010, 185:2828-2835.
24. Chapman H.A. Endosomal proteases in antigen presentation. Curr Opin Immunol 2006, 18:78-84.
25. Conus S., Simon H.U. Cathepsins and their involvement in immune responses. Swiss Med Wkly 2010, 140:w13042.
26. van Ham M., van Lith M., Lillemeier B., Tjin E., Gruneberg U., Rahman D., Pastoors L., van Meijgaarden K., Roucard C., Trowsdale J., et al. Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO. J Exp Med 2000, 191:1127-1136.
27. Draghi N.A., Denzin L.K. H2-O, a MHC class II-like protein, sets a threshold for B-cell entry into germinal centers. Proc Natl Acad Sci U S A 2010, 107:16607-16612.
28. Yi W., Seth N.P., Martillotti T., Wucherpfennig K.W., Sant'Angelo D.B., Denzin L.K. Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence. J Clin Invest 2010, 120:1324-1336.
29. Ziegler H.K., Unanue E.R. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci U S A 1982, 79:175-178.
30. Call M.J., Xing X., Cuny G.D., Seth N.P., Altmann D.M., Fugger L., Krogsgaard M., Stein R.L., Wucherpfennig K.W. In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchange. J Immunol 2009, 182:6342-6352.
31. Burster T., Boehm B.O. Processing and presentation of (pro)-insulin in the MHC class II pathway: the generation of antigen-based immunomodulators in the context of type 1 diabetes mellitus. Diabetes Metab Res Rev 2010, 26:227-238.
32. Hammond C., Denzin L.K., Pan M., Griffith J.M., Geuze H.J., Cresswell P. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR-DM, and -DO molecules. J Immunol 1998, 161:3282-3291.
33. Escola J.M., Deleuil F., Stang E., Boretto J., Chavrier P., Gorvel J.P. Characterization of a lysozyme-major histocompatibility complex class II molecule-loading compartment as a specialized recycling endosome in murine B lymphocytes. J Biol Chem 1996, 271:27360-27365.
34. Wubbolts R., Leckie R.S., Veenhuizen P.T., Schwarzmann G., Mobius W., Hoernschemeyer J., Slot J.W., Geuze H.J., Stoorvogel W. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem 2003, 278:10963-10972.
35. Buschow S.I., van Balkom B.W., Aalberts M., Heck A.J., Wauben M., Stoorvogel W. MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis. Immunol Cell Biol 2010, 88:851-856.
36. Koppelman B., Neefjes J.J., de Vries J.E., Waal Malefyt R. Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 1997, 7:861-871.
37. Engering A., Kuhn L., Fluitsma D., Hoefsmit E., Pieters J. Differential post-translational modification of CD63 molecules during maturation of human dendritic cells. Eur J Biochem 2003, 270:2412-2420.
38. Deutsch E.W., Eng J.K., Zhang H., King N.L., Nesvizhskii A.I., Lin B., Lee H., Yi E.C., Ossola R., Aebersold R. Human Plasma PeptideAtlas. Proteomics 2005, 5:3497-3500.
39. Simpson R.J., Lim J.W., Moritz R.L., Mathivanan S. Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics 2009, 6:267-283.
40. Arnold P.Y., Mannie M.D. Vesicles bearing MHC class II molecules mediate transfer of antigen from antigen-presenting cells to CD4+ T cells. Eur J Immunol 1999, 29:1363-1373.
41. Thery C., Duban L., Segura E., Veron P., Lantz O., Amigorena S. Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol 2002, 3:1156-1162.
42. Nolte-'t Hoen E.N., Buschow S.I., Anderton S.M., Stoorvogel W., Wauben M.H. Activated T cells recruit exosomes secreted by dendritic cells via LFA-1. Blood 2009, 113:1977-1981.
43. Segura E., Guerin C., Hogg N., Amigorena S., Thery C. CD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo. J Immunol 2007, 179:1489-1496.
44. Szajnik M., Czystowska M., Szczepanski M.J., Mandapathil M., Whiteside T.L. Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS One 2010, 5:e11469.
45. Schnitzer J.K., Berzel S., Fajardo-Moser M., Remer K.A., Moll H. Fragments of antigen-loaded dendritic cells (DC) and DC-derived exosomes induce protective immunity against Leishmania major. Vaccine 2010, 28:5785-5793.
46. Thery C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009, 9:581-593.
47. De La Pena H., Madrigal J.A., Rusakiewicz S., Bencsik M., Cave G.W., Selman A., Rees R.C., Travers P.J., Dodi I.A. Artificial exosomes as tools for basic and clinical immunology. J Immunol Methods 2009, 344:121-132.
48. Wubbolts R., Fernandez-Borja M., Jordens I., Reits E., Dusseljee S., Echeverri C., Vallee R.B., Neefjes J. Opposing motor activities of dynein and kinesin determine retention and transport of MHC class II-containing compartments. J Cell Sci 1999, 112(Part 6):785-795.
49. Boes M., Bertho N., Cerny J., Op den Brouw M., Kirchhausen T., Ploegh H. T cells induce extended class II MHC compartments in dendritic cells in a Toll-like receptor-dependent manner. J Immunol 2003, 171:4081-4088.
50. Chow A., Toomre D., Garrett W., Mellman I. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 2002, 418:988-994.
51. Kleijmeer M., Ramm G., Schuurhuis D., Griffith J., Rescigno M., Ricciardi-Castagnoli P., Rudensky A.Y., Ossendorp F., Melief C.J., Stoorvogel W., Geuze H.J. Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells. J Cell Biol 2001, 155:53-63.
52. Kuipers H.F., Biesta P.J., Groothuis T.A., Neefjes J.J., Mommaas A.M., van den Elsen P.J. Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains. Hum Immunol 2005, 66:653-665.
53. Rocha N., Kuijl C., van der Kant R., Janssen L., Houben D., Janssen H., Zwart W., Neefjes J. Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILP-p150 Glued and late endosome positioning. J Cell Biol 2009, 185:1209-1225.
54. Ostrowski M., Carmo N.B., Krumeich S., Fanget I., Raposo G., Savina A., Moita C.F., Schauer K., Hume A.N., Freitas R.P., et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 2010, 12:19-30.
55. Gauvreau M.E., Cote M.H., Bourgeois-Daigneault M.C., Rivard L.D., Xiu F., Brunet A., Shaw A., Steimle V., Thibodeau J. Sorting of MHC class II molecules into exosomes through a ubiquitin-independent pathway. Traffic 2009, 10:1518-1527.
56. Buschow S.I., Nolte-'t Hoen E.N., van Niel G., Pols M.S., ten Broeke T., Lauwen M., Ossendorp F., Melief C.J., Raposo G., Wubbolts R., et al. MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic 2009, 10:1528-1542.
57. Simonsen A., Bremnes B., Nordeng T.W., Bakke O. The leucine-based motif DDQxxLI is recognized both for internalization and basolateral sorting of invariant chain in MDCK cells. Eur J Cell Biol 1998, 76:25-32.
58. Thibodeau J., Bourgeois-Daigneault M.C., Huppe G., Tremblay J., Aumont A., Houde M., Bartee E., Brunet A., Gauvreau M.E., de Gassart A., et al. Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes. Eur J Immunol 2008, 38:1225-1230.
59. de Gassart A., Camosseto V., Thibodeau J., Ceppi M., Catalan N., Pierre P., Gatti E. MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proc Natl Acad Sci U S A 2008, 105:3491-3496.
60. Nathan J.A., Lehner P.J. The trafficking and regulation of membrane receptors by the RING-CH ubiquitin E3 ligases. Exp Cell Res 2009, 315:1593-1600.
61. Mitchell E.K., Mastroeni P., Kelly A.P., Trowsdale J. Inhibition of cell surface MHC class II expression by Salmonella. Eur J Immunol 2004, 34:2559-2567.
62. Cheminay C., Mohlenbrink A., Hensel M. Intracellular Salmonella inhibit antigen presentation by dendritic cells. J Immunol 2005, 174:2892-2899.
63. Lapaque N., Jahnke M., Trowsdale J., Kelly A.P. The HLA-DRalpha chain is modified by polyubiquitination. J Biol Chem 2009, 284:7007-7016.
64. Chaudhry A., Verghese D.A., Das S.R., Jameel S., George A., Bal V., Mayor S., Rath S. HIV-1 Nef promotes endocytosis of cell surface MHC class II molecules via a constitutive pathway. J Immunol 2009, 183:2415-2424.
65. Pathak S.S., Lich J.D., Blum J.S. Cutting edge: editing of recycling class II:peptide complexes by HLA-DM. J Immunol 2001, 167:632-635.
66. Sinnathamby G., Eisenlohr L.C. Presentation by recycling MHC class II molecules of an influenza hemagglutinin-derived epitope that is revealed in the early endosome by acidification. J Immunol 2003, 170:3504-3513.
67. Walseng E., Bakke O., Roche P.A. Major histocompatibility complex class II-peptide complexes internalize using a clathrin- and dynamin-independent endocytosis pathway. J Biol Chem 2008, 283:14717-14727.
68. Fernandez-Borja M., Verwoerd D., Sanderson F., Aerts H., Trowsdale J., Tulp A., Neefjes J. HLA-DM and MHC class II molecules co-distribute with peptidase-containing lysosomal subcompartments. Int Immunol 1996, 8:625-640.
69. Burster T., Macmillan H., Hou T., Schilling J., Truong P., Boehm B.O., Zou F., Lau K., Strohman M., Schaffert S., et al. Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules. Immunology 2010, 130:436-446.
70. Reich M., Wieczerzak E., Jankowska E., Palesch D., Boehm B.O., Burster T. Specific cathepsin B inhibitor is cell-permeable and activates presentation of TTC in primary human dendritic cells. Immunol Lett 2009, 123:155-159.
71. Reich M., Lesner A., Legowska A., Sienczyk M., Oleksyszyn J., Boehm B.O., Burster T. Application of specific cell permeable cathepsin G inhibitors resulted in reduced antigen processing in primary dendritic cells. Mol Immunol 2009, 46:2994-2999.
72. Cai J., Baugh M., Black D., Long C., Jonathan Bennett D., Dempster M., Fradera X., Gillespie J., Andrews F., Boucharens S., et al. 6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors. Bioorg Med Chem Lett 2010, 20:4350-4354.
73. Cai J., Bennett D.J., Rankovic Z., Dempster M., Fradera X., Gillespie J., Cumming I., Finlay W., Baugh M., Boucharens S., et al. 2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors. Bioorg Med Chem Lett 2010, 20:4447-4450.
74. Takahashi K., Ueno T., Tanida I., Minematsu-Ikeguchi N., Murata M., Kominami E. Characterization of CAA0225, a novel inhibitor specific for cathepsin L, as a probe for autophagic proteolysis. Biol Pharm Bull 2009, 32:475-479.